Company intelligence / Profile preview

SICPA

Prilly, Vaud, Switzerlandsicpa.com ↗

Ownership: Private
Employees: ~3000
Development stage: Commercial

Overview

SICPA’s life science-related offerings include secure marking of pharmaceuticals with DNA or molecular tags to prevent counterfeiting, digital platforms aggregating public health data for crisis management, and lab-on-chip diagnostics. These technologies are commercially deployed to support governments in authenticating medicines, monitoring supply chains, managing epidemiological threats, and ensuring the integrity of medical products.

Modalities: Device (e.g., lab-on-chip diagnostics)DNA marker technology for authentication
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on SICPA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SICPA.

Explore the full profile